ClinicalTrials.Veeva

Menu

Surveillance and Medical Help for HIV-infected Intravenous Drug Users in and Out of Prison

K

Kaohsiung Medical University

Status

Completed

Conditions

HIV Infections

Study type

Observational

Funder types

Other
Other U.S. Federal agency

Identifiers

NCT00739258
KMUH-IRB-970077

Details and patient eligibility

About

It is difficult to detect the intestinal protozoal infections among the HIV-infected persons or travelers diarrhea by using the traditional microscopy or staining methods. The purpose of this study aimed at finding out the appropriate diagnostic methods and the infection rate of the intestinal protozoa, including the Entamoeba, Cryptosporidium and Giardia among the HIV-infected persons by using the antigen detection method and biological method. The investigators also tried to analyze the associated HIV infection status and sexual transmitted diseases (STD) including Gonorrhea, Chlamydial trachomatis, Syphilis, Genital warts and Herpes simplex virus in this study. The study will collect the blood, urine and stool samples from 200 intravenous drug user (IDU) with HIV-infected in the prisons, 400 intravenous drug user (IDU) without HIV infected and 100 intravenous drug user (IDU) with HIV infected receiving methadone maintenance treatment.

Enrollment

700 estimated patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Clinical diagnosis of HIV
  • Receiving Methadone Maintenance Treatment
  • intravenous drug user (IDU)

Trial design

700 participants in 3 patient groups

HIDU
Description:
intravenous drug user (IDU) with HIV infected
IDU
Description:
intravenous drug user (IDU) without HIV
MH
Description:
persons receiving methadone maintenance treatment

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems